Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Effects of vitamin E and physical therapy in alleviating the symptoms of vulva pruritus: A review of 49 cases.
Afr J Reprod Health
October 2024
Department of Gynecology, Huai'an First People's Hospital, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu 223300, China.
This was a retrospective study. Vulva pruritus is a common symptom in gynaecology and causes mental burden in patients. This study aimed to analyze effects of the Vitamin E and physical therapy on alleviating the symptoms of vulva pruritus.
View Article and Find Full Text PDFA review of the traditional uses, phytochemistry, pharmacology, and clinical evidence for the use of the genus Alchemilla (Rosaceae).
J Ethnopharmacol
February 2024
Department of Pharmacognosy, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, Ul. Mickiewicza 2a, 15-230 Białystok, Poland. Electronic address:
Ethnopharmacological Relevance: The genus Alchemilla L. (lady's mantle) comprises 1000 species, of which more than 300 have been characterized from Europe. Notably, as folk medicines, Alchemilla species have long been prescribed for the treatment of dysmenorrhea, pruritus vulvae, menopausal complaints, and related diseases in women.
View Article and Find Full Text PDFVulvar syringoma: A rare cause of pruritus vulvae.
Indian J Sex Transm Dis AIDS
June 2022
Department of Dermatology, Venereology and Leprosy, Vijayanagara Institute of Medical Sciences, Ballari, Karnataka, India.
Syringomas commonly occur in women over the face, neck, and chest. They are usually asymptomatic and mainly of cosmetic concern. The vulva is an uncommon site for syringomas.
View Article and Find Full Text PDFContext: Kundur, Boswellia serrata Roxb. ex Colebr., is prescribed by Unani (Greco-Arab) scholars clinically under conditions similar to vulvovaginal candidiasis (VVC) and has been supported by recent pharmacological studies, but scientific evidence is scarce.
View Article and Find Full Text PDFEfficacy of canagliflozin versus metformin in women with polycystic ovary syndrome: A randomized, open-label, noninferiority trial.
Diabetes Obes Metab
February 2022
Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Objectives: To determine the safety and efficacy of canagliflozin in comparison to metformin in polycystic ovary syndrome (PCOS) patients with insulin resistance (IR).
Methods: A single-centre, prospective, randomized open-label (ratio 1:1) noninferiority trial was conducted at the Department of Endocrinology, Shanghai Tenth People's Hospital, between July 2019 and April 2021. Women aged 18 to 45 years with PCOS and IR were enrolled and randomly assigned to either 100 mg (n = 33) canagliflozin daily or 1500 to 2000 mg metformin daily (n = 35) for 12 weeks.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!